Prospective Cohort of Acute Cardiology Referrals in an Ambulatory Day-Hospital Setting
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Acute Coronary Syndromes, Heart Failure, Pulmonary Embolism, Deep Vein Thrombosis, HTN-Hypertension. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- Center list to be confirmed — check the primary protocol.
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
CESAR Study: Prospective Cohort of Consecutive Patients Undergoing Cardiologic Evaluation in a Specialized Ambulatory Referral Unit
Overview
Suspected acute or subacute cardiovascular diseases-including chest pain, dyspnea, and palpitations-are among the most common reasons for unscheduled emergency department visits and pre-hospital referrals. Despite this high clinical burden, the diagnostic yield is often limited, with a frequent mismatch between initial clinical suspicion and final diagnosis, contributing to substantial healthcare utilization and hospitalization rates. Current evidence is largely focused on specific conditions such as acute coronary syndromes, heart failure, arrhythmias, or pulmonary embolism, and rarely integrates the full spectrum of clinical, biological, and imaging data obtained during initial evaluation. To address this gap, we will establish a prospective cohort of all consecutive patients referred to the ambulatory day-hospital cardiology unit at Lariboisière University Hospital. This unit acts as a specialized downstream referral structure within the emergency care pathway, receiving patients after triage by emergency physicians, pre-hospital regulation services (SAMU), mobile intensive care units (SMUR), or emergency departments. Although it does not capture all suspected cardiovascular emergencies, it represents a selected real-world population deemed to require specialized acute cardiology assessment. The primary objective is to assess the frequency of cardiac conditions diagnosed in this cohort. Secondary objectives include characterization of patient profiles and diagnostic pathways; evaluation of the diagnostic and prognostic performance of clinical, biological, imaging, and multimodal parameters using final Heart Team diagnosis as reference; analysis of prior health history and healthcare utilization; and assessment of the medico-economic burden of suspected acute cardiovascular disease. The study will further support the development of a dedicated biobank and the validation of next-generation biomarkers, including AI-driven and voice-based markers, as well as decision-support algorithms for binary classification of cardiac involvement. Through integration of multimodal data and linkage with national health records, this approach aims to improve diagnostic accuracy, risk stratification, and understanding of the healthcare impact of acute cardiovascular presentations in a real-world setting.
Primary outcome measures
- Proportion of patients with confirmed cardiovascular diagnosis among consecutive patients consulting for suspicion of acute or sub-acute cardiovascular disease at the ambulatory day-hospital unit. [Time frame: From enrollement to six months of follow-up.]
Secondary outcome measures (12)
- Proportion referred to cardiac computed tomography (CCT) [Time frame: From enrollement to six months of follow-up.]
- Proportion referred to cardiovascular magnetic resonance (CMR) [Time frame: From enrollement to six months of follow-up.]
- Proportion referred to stress tests. [Time frame: From enrollement to six months of follow-up.]
- Proportion referred to Holter monitoring or implantable loop recorders [Time frame: From enrollement to six months of follow-up.]
- Proportion with introduction of heart failure (HF) therapy [Time frame: From enrollement to six months of follow-up.]
- Proportion with introduction of anti-platelet therapy [Time frame: From enrollement to six months of follow-up.]
- Proportion with introduction of anti-coagulant therapy [Time frame: From enrollement to six months of follow-up.]
- Proportion referred to percutaneous coronary intervention (PCI) [Time frame: From enrollement to six months of follow-up.]
- Proportion referred to cardiac surgery [Time frame: From enrollement to six months of follow-up.]
- Proportion referred to electrical cardioversion [Time frame: From enrollement to six months of follow-up.]
- Proportion referred to catheter ablation [Time frame: From enrollement to six months of follow-up.]
- Proportion referred to pacemaker implantation [Time frame: From enrollement to six months of follow-up.]
Eligibility criteria
Inclusion criteria
\- The study will include all consecutive patients referred to ambulatory day-hospital unit for suspicion of acute or sub-acute cardiovascular disease at the Cardiology Department of Lariboisière University Hospital.
Exclusion criteria
- Patient unable to provide informed consent
- Patient not affiliated to French social security
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Observational model
- Cohort
Study locations
Center list to be confirmed — check the primary protocol.
Identifiers
NCT: NCT07675434 · APHP260122